Total Payments
$941.11
2024 Payments
$141.52
Companies
15
Transactions
33
Medicare Patients
186
Medicare Billing
$16,119
Payment Breakdown by Category
Food & Beverage$941.11 (100.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $941.11 | 33 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| AstraZeneca Pharmaceuticals LP | $191.84 | 5 | $0 (2024) |
| Amarin Pharma Inc. | $124.21 | 1 | $0 (2019) |
| PFIZER INC. | $123.68 | 3 | $0 (2023) |
| Avanir Pharmaceuticals, Inc. | $104.60 | 1 | $0 (2017) |
| Novo Nordisk Inc | $104.47 | 6 | $0 (2023) |
| ABBVIE INC. | $69.37 | 3 | $0 (2023) |
| Sumitomo Pharma America, Inc. | $52.62 | 4 | $0 (2024) |
| Amgen Inc. | $48.60 | 3 | $0 (2024) |
| Dexcom, Inc. | $24.78 | 1 | $0 (2023) |
| Insulet Corporation | $23.02 | 1 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $141.52 | 8 | Amgen Inc. ($37.43) |
| 2023 | $243.25 | 13 | ABBVIE INC. ($69.37) |
| 2022 | $31.69 | 2 | Novo Nordisk Inc ($19.13) |
| 2020 | $28.78 | 2 | Novo Nordisk Inc ($17.61) |
| 2019 | $391.27 | 7 | Amarin Pharma Inc. ($124.21) |
| 2017 | $104.60 | 1 | Avanir Pharmaceuticals, Inc. ($104.60) |
All Payment Transactions
33 individual payment records from CMS Open Payments — Page 1 of 2
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/10/2024 | Amgen Inc. | KRYSTEXXA (Biological) | Food and Beverage | In-kind items and services | $14.25 | General |
| Category: Inflammation/Rare Disease | ||||||
| 11/13/2024 | Abbott Laboratories | PROCLAIM (Device) | Food and Beverage | In-kind items and services | $17.74 | General |
| Category: Neuromodulation | ||||||
| 11/11/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $14.77 | General |
| Category: Diabetes | ||||||
| 11/08/2024 | Amgen Inc. | KRYSTEXXA (Biological) | Food and Beverage | In-kind items and services | $23.18 | General |
| Category: Inflammation/Rare Disease | ||||||
| 03/18/2024 | Sumitomo Pharma America, Inc. | GEMTESA (Drug) | Food and Beverage | In-kind items and services | $15.88 | General |
| Category: UROLOGY | ||||||
| 02/21/2024 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $19.57 | General |
| Category: Respiratory | ||||||
| 02/09/2024 | Sumitomo Pharma America, Inc. | GEMTESA (Drug) | Food and Beverage | In-kind items and services | $13.11 | General |
| Category: UROLOGY | ||||||
| 01/23/2024 | Insulet Corporation | Omnipod (Device) | Food and Beverage | Cash or cash equivalent | $23.02 | General |
| Category: Insulin Pump | ||||||
| 11/30/2023 | Sumitomo Pharma America, Inc. | APTIOM (Drug) | Food and Beverage | In-kind items and services | $15.38 | General |
| Category: CNS | ||||||
| 11/16/2023 | Sumitomo Pharma America, Inc. | APTIOM (Drug) | Food and Beverage | In-kind items and services | $8.25 | General |
| Category: CNS | ||||||
| 09/20/2023 | Dexcom, Inc. | Dexcom G6 Transmitter (Medical Supply) | Food and Beverage | In-kind items and services | $24.78 | General |
| Category: Endocrinology | ||||||
| 09/19/2023 | ABBVIE INC. | LINZESS (Drug) | Food and Beverage | In-kind items and services | $25.59 | General |
| Category: GASTROENTEROLOGY | ||||||
| 08/23/2023 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $19.49 | General |
| Category: Respiratory | ||||||
| 08/17/2023 | ABBVIE INC. | VIBERZI (Drug), LINZESS | Food and Beverage | In-kind items and services | $25.99 | General |
| Category: GASTROENTEROLOGY | ||||||
| 08/03/2023 | PFIZER INC. | PREVNAR 20 (Biological), COMIRNATY, ABRYSVO | Food and Beverage | In-kind items and services | $19.90 | General |
| Category: VACCINES | ||||||
| 06/08/2023 | ABBVIE INC. | VIBERZI (Drug), LINZESS | Food and Beverage | In-kind items and services | $17.79 | General |
| Category: GASTROENTEROLOGY | ||||||
| 06/01/2023 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $18.35 | General |
| Category: Respiratory | ||||||
| 05/18/2023 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $14.45 | General |
| Category: Diabetes | ||||||
| 04/11/2023 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $16.78 | General |
| Category: Obesity | ||||||
| 02/21/2023 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $17.04 | General |
| Category: Diabetes | ||||||
| 01/04/2023 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $19.46 | General |
| Category: Diabetes | ||||||
| 12/15/2022 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $19.13 | General |
| Category: Diabetes | ||||||
| 08/25/2022 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $12.56 | General |
| Category: Respiratory | ||||||
| 02/04/2020 | Novo Nordisk Inc | Saxenda (Drug) | Food and Beverage | In-kind items and services | $17.61 | General |
| Category: Obesity | ||||||
| 01/27/2020 | Amgen Inc. | EVENITY (Biological), Prolia | Food and Beverage | In-kind items and services | $11.17 | General |
| Category: Bone Health | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 3 | 76 | 88 | $29,949 | $8,113 |
| 2020 | 3 | 110 | 149 | $27,443 | $8,005 |
Total Patients
186
Total Services
237
Medicare Billing
$16,119
Procedure Codes
6
All Medicare Procedures & Services
6 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 32 | 42 | $15,750 | $4,127 | 26.2% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 31 | 33 | $9,405 | $2,336 | 24.8% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 13 | 13 | $4,794 | $1,651 | 34.4% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 80 | 118 | $26,443 | $7,692 | 29.1% |
| G2012 | Brief communication technology-based service, e.g. virtual check-in, by a physician or other qualified health care professional who can report evaluation and management services, provided to an established patient, not originating from a related e/m servic | Office | 2020 | 15 | 15 | $439.82 | $157.92 | 35.9% |
| 83036 | Hemoglobin a1c level | Office | 2020 | 15 | 16 | $560.00 | $155.36 | 27.7% |
About Dr. Jerry Mckenzie, M.D
Dr. Jerry Mckenzie, M.D is a Emergency Medicine healthcare provider based in Mansfield, Texas. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 04/23/2012. The National Provider Identifier (NPI) number assigned to this provider is 1053679407.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Jerry Mckenzie, M.D has received a total of $941.11 in payments from pharmaceutical and medical device companies, with $141.52 received in 2024. These payments were reported across 33 transactions from 15 companies. The most common payment nature is "Food and Beverage" ($941.11).
As a Medicare-enrolled provider, Mckenzie has provided services to 186 Medicare beneficiaries, totaling 237 services with total Medicare billing of $16,119. Data is available for 2 years (2020–2023), covering 6 distinct procedure/service records.
Ad
Practice Information
- Specialty Emergency Medicine
- Other Specialties Student in an Organized Health Care Education/Training Program, Geriatric Medicine
- Location Mansfield, TX
- Active Since 04/23/2012
- Last Updated 12/11/2024
- Taxonomy Code 207P00000X
- Entity Type Individual
- NPI Number 1053679407
Products in Payments
- Vascepa (Drug) $124.21
- FARXIGA (Drug) $121.87
- NUEDEXTA (Drug) $104.60
- TRUMENBA (Biological) $90.71
- BREZTRI (Drug) $69.97
- VIBERZI (Drug) $43.78
- Ozempic (Drug) $38.59
- KRYSTEXXA (Biological) $37.43
- Rybelsus (Drug) $31.49
- GEMTESA (Drug) $28.99
- LINZESS (Drug) $25.59
- Dexcom G6 Transmitter (Medical Supply) $24.78
- APTIOM (Drug) $23.63
- Omnipod (Device) $23.02
- PREVNAR 20 (Biological) $19.90
- PROCLAIM (Device) $17.74
- Saxenda (Drug) $17.61
- Wegovy (Drug) $16.78
- MOUNJARO (Drug) $14.77
- Mirena (Drug) $14.50
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Emergency Medicine Doctors in Mansfield
Mr. Warren Roquet, Md, MD
Emergency Medicine — Payments: $10,966
Emergency Medicine $10,966
Shoaib Saya, M.d, M.D
Emergency Medicine — Payments: $8,260
Emergency Medicine $8,260
Kimberli Omwanghe, M.d, M.D
Emergency Medicine — Payments: $571.55
Emergency Medicine $571.55
Alan Goodrich, Do, DO
Emergency Medicine — Payments: $459.30
Emergency Medicine $459.30
Joseph Bocka, Md, MD
Emergency Medicine — Payments: $417.21
Emergency Medicine $417.21
Michael Mccrea, Md, MD
Emergency Medicine — Payments: $277.29
Emergency Medicine $277.29